Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2018 Sep 3:2018:4723167.
doi: 10.1155/2018/4723167. eCollection 2018.

Treatment Outcomes of Patients with Squamous Cell Carcinoma of the Vulva: The Largest Series from a Tertiary Care Hospital

Panida Meelapkij  1 , Prapaporn Suprasert  1 , Orthai Baisai  1
Affiliations

Treatment Outcomes of Patients with Squamous Cell Carcinoma of the Vulva: The Largest Series from a Tertiary Care Hospital

Panida Meelapkij et al. Obstet Gynecol Int. .

Abstract

Objective: To evaluate the outcomes of squamous cell carcinoma (SCCA) of the vulva treated at our tertiary care center.

Methods: The medical records of SCCA patients treated between January 2006 and December 2015 were retrospectively reviewed.

Results: One hundred forty-five patients met the criteria with the median age of 57 years old, and 58.6% had an underlying disease. The distribution of stages was as follows: IA 6.2%, IB 21.4%, II 26.2%, IIIA 14.5%, IIIB 6.2%, IIIC 9.7%, IVA 9.0%, and IVB 6.9%. One hundred and nine patients underwent surgical intervention and radical local excision with bilateral groin node dissection as the most frequent procedure. Approximately half of the patients received combined treatment with surgery followed by radiation with or without chemotherapy. Recurrence developed in 127 patients after the median follow-up time of one year with the common sites in the groin and vulva region. However, no significant difference in survival occurred in patients with and without groin node recurrence (15 vs. 28 months, P=0.109). The five-year overall survival was 50.8%.

Conclusions: The survival of patients with SCCA vulvar cancer was modest. The common failure sites were groin and vulva regions with unfavorable outcomes.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Estimated overall survival (N = 145). Median overall survival = 59 months (1–132 months), 5-year overall survival = 50.8%, death = 72 (49.7%), and alive = 73 (50.3%).
Figure 2
Figure 2
Estimated overall survival divided by stage.
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

References

    1. Chokoeva A. A, Tchernev G., Castelli E., et al. Vulvar cancer: a review for dermatologists. Wiener Medizinische Wochenschrift. 2015;165(7-8):164–177. doi: 10.1007/s10354-015-0354-9. - DOI - PubMed
    1. de Sanjosé S., Alemany L., Ordi J., et al. Worldwide human papillomavirus genotype attribution in over 2000 cases of intraepithelial and invasive lesions of the vulva. European Journal of Cancer. 2013;49(16):3450–3461. doi: 10.1016/j.ejca.2013.06.033. - DOI - PubMed
    1. Alkatout I., Schubert M., Garbrecht N., et al. Vulvar cancer: epidemiology, clinical presentation, and management options. International Journal of Women’s Health. 2015;7:305–313. doi: 10.2147/ijwh.s68979. - DOI - PMC - PubMed
    1. Preti M., Scurry J., Marchitelli C. E., Micheletti L. Vulvar intraepithelial neoplasia. Best Practice & Research Clinical Obstetrics & Gynaecology. 2014;28(7):1051–1062. doi: 10.1016/j.bpobgyn.2014.07.010. - DOI - PubMed
    1. Dittmer C., Katalinic A., Mundhenke C., Thill M., Fischer D. Epidemiology of vulvar and vaginal cancer in Germany. Archives of Gynecology and Obstetrics. 2011;284(1):169–174. doi: 10.1007/s00404-011-1850-9. - DOI - PubMed

LinkOut - more resources